TY - JOUR AU - Balch, C. AU - Buzaid, A. AU - Soong, S. AU - Atkins, M. AU - Cascinelli, N. AU - Coit, D. AU - Fleming, I. AU - Gershenwald, J. AU - Houghton, A. AU - Kirkwood, J. PY - 2001 DA - 2001// TI - Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma JO - J Clin Oncol VL - 19 ID - Balch2001 ER - TY - JOUR AU - Helmbach, H. AU - Sinha, P. AU - Schadendorf, D. PY - 2003 DA - 2003// TI - Human melanoma: drug resistance JO - Recent Results Cancer Res VL - 161 UR - https://doi.org/10.1007/978-3-642-19022-3_9 DO - 10.1007/978-3-642-19022-3_9 ID - Helmbach2003 ER - TY - JOUR AU - Campoli, M. R. AU - Chang, C. C. AU - Kageshita, T. AU - Wang, X. AU - McCarthy, J. B. AU - Ferrone, S. PY - 2004 DA - 2004// TI - Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance 1 JO - Crit Rev Immunol VL - 24 UR - https://doi.org/10.1615/CritRevImmunol.v24.i4.40 DO - 10.1615/CritRevImmunol.v24.i4.40 ID - Campoli2004 ER - TY - JOUR AU - Vergilis, I. AU - Szarek, M. AU - Ferrone, S. AU - Reynolds, S. PY - 2005 DA - 2005// TI - Presence and Prognostic Significance of Melanoma-Associated Antigens CYT-MAA and HMW-MAA in Serum of Patients with Melanoma JO - J Investig Dermatol VL - 125 UR - https://doi.org/10.1111/j.0022-202X.2005.23798.x DO - 10.1111/j.0022-202X.2005.23798.x ID - Vergilis2005 ER - TY - JOUR AU - Eisenmann, K. M. AU - McCarthy, J. B. AU - Simpson, M. A. AU - Keely, P. J. AU - Guan, J. L. AU - Tachibana, K. AU - Lim, L. AU - Manser, E. AU - Furcht, L. T. AU - Iida, J. PY - 1999 DA - 1999// TI - Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas JO - Nat Cell Biol VL - 1 UR - https://doi.org/10.1038/70302 DO - 10.1038/70302 ID - Eisenmann1999 ER - TY - JOUR AU - Yang, J. AU - Price, M. A. AU - Neudauer, C. L. AU - Wilson, C. AU - Ferrone, S. AU - Xia, H. AU - Iida, J. AU - Simpson, M. A. AU - McCarthy, J. B. PY - 2004 DA - 2004// TI - Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms JO - J Cell Biol VL - 165 UR - https://doi.org/10.1083/jcb.200403174 DO - 10.1083/jcb.200403174 ID - Yang2004 ER - TY - JOUR AU - Yang, J. AU - Price, M. A. AU - Li, G. Y. AU - Bar-Eli, M. AU - Salgia, R. AU - Jagedeeswaran, R. AU - Carlson, J. H. AU - Ferrone, S. AU - Turley, E. A. AU - McCarthy, J. B. PY - 2009 DA - 2009// TI - Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-4626 DO - 10.1158/0008-5472.CAN-08-4626 ID - Yang2009 ER - TY - JOUR AU - Iida, J. AU - Wilhelmson, K. L. AU - Ng, J. AU - Lee, P. AU - Morrison, C. AU - Tam, E. AU - Overall, C. M. AU - McCarthy, J. B. PY - 2007 DA - 2007// TI - Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A) JO - Biochem J VL - 403 UR - https://doi.org/10.1042/BJ20061176 DO - 10.1042/BJ20061176 ID - Iida2007 ER - TY - JOUR AU - Chang, C. C. AU - Campoli, M. AU - Luo, W. AU - Zhao, W. AU - Zaenker, K. S. AU - Ferrone, S. PY - 2004 DA - 2004// TI - Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms JO - Ann N Y Acad Sci VL - 1028 UR - https://doi.org/10.1196/annals.1322.040 DO - 10.1196/annals.1322.040 ID - Chang2004 ER - TY - JOUR AU - Schwenkert, M. AU - Birkholz, K. AU - Schwemmlein, M. AU - Kellner, C. AU - Kugler, M. AU - Peipp, M. AU - Nettelbeck, D. M. AU - Schuler-Thurner, B. AU - Schaft, N. AU - Dorrie, J. PY - 2008 DA - 2008// TI - A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells JO - Melanoma Res VL - 18 UR - https://doi.org/10.1097/CMR.0b013e3282f7c8f9 DO - 10.1097/CMR.0b013e3282f7c8f9 ID - Schwenkert2008 ER - TY - JOUR AU - Mittelman, A. AU - Chen, Z. J. AU - Yang, H. AU - Wong, G. Y. AU - Ferrone, S. PY - 1992 DA - 1992// TI - Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma JO - Proceedings of the National Academy of Sciences of the United States of America VL - 89 UR - https://doi.org/10.1073/pnas.89.2.466 DO - 10.1073/pnas.89.2.466 ID - Mittelman1992 ER - TY - JOUR AU - Ashkenazi, A. AU - Pai, R. C. AU - Fong, S. AU - Leung, S. AU - Lawrence, D. A. AU - Marsters, S. A. AU - Blackie, C. AU - Chang, L. AU - McMurtrey, A. E. AU - Hebert, A. PY - 1999 DA - 1999// TI - Safety and antitumor activity of recombinant soluble Apo2 ligand JO - J Clin Invest VL - 104 UR - https://doi.org/10.1172/JCI6926 DO - 10.1172/JCI6926 ID - Ashkenazi1999 ER - TY - JOUR AU - Soria, J. AU - Smit, E. AU - Khayat, D. AU - Besse, B. AU - Yang, X. AU - Hsu, C. AU - Reese, D. AU - Wiezorek, J. AU - Blackhall, F. PY - 2010 DA - 2010// TI - Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer JO - J Clin Oncol VL - 9 UR - https://doi.org/10.1200/JCO.2009.25.4847 DO - 10.1200/JCO.2009.25.4847 ID - Soria2010 ER - TY - JOUR AU - Bremer, E. AU - Kuijlen, J. AU - Samplonius, D. AU - Walczak, H. AU - de Leij, L. AU - Helfrich, W. PY - 2004 DA - 2004// TI - Target cell-restricted and -enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma-associated antigen EGP2 1 JO - Int J Cancer VL - 109 UR - https://doi.org/10.1002/ijc.11702 DO - 10.1002/ijc.11702 ID - Bremer2004 ER - TY - JOUR AU - Bremer, E. AU - Samplonius, D. AU - Kroesen, B. J. AU - van Genne, L. AU - de Leij, L. AU - Helfrich, W. PY - 2004 DA - 2004// TI - Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cells JO - Neoplasia VL - 6 UR - https://doi.org/10.1593/neo.04229 DO - 10.1593/neo.04229 ID - Bremer2004 ER - TY - JOUR AU - Bremer, E. AU - Samplonius, D. F. AU - van Genne, L. AU - Dijkstra, M. H. AU - Kroesen, B. J. AU - de Leij, L. F. AU - Helfrich, W. PY - 2005 DA - 2005// TI - Simultaneous inhibition of epidermal growth factor receptor (EGFR) signaling and enhanced activation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-mediated apoptosis induction by an scFv:sTRAIL fusion protein with specificity for human EGFR JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M413673200 DO - 10.1074/jbc.M413673200 ID - Bremer2005 ER - TY - JOUR AU - Bremer, E. AU - Samplonius, D. F. AU - Peipp, M. AU - van Genne, L. AU - Kroesen, B. J. AU - Fey, G. H. AU - Gramatzki, M. AU - de Leij, L. F. AU - Helfrich, W. PY - 2005 DA - 2005// TI - Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7 JO - Cancer Res VL - 65 ID - Bremer2005 ER - TY - JOUR AU - Bremer, E. AU - de Bruyn, M. AU - Samplonius, D. F. AU - Bijma, T. AU - Ten Cate, B. AU - de Leij, L. F. AU - Helfrich, W. PY - 2008 DA - 2008// TI - Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells JO - J Mol Med VL - 86 UR - https://doi.org/10.1007/s00109-008-0348-9 DO - 10.1007/s00109-008-0348-9 ID - Bremer2008 ER - TY - JOUR AU - Bremer, E. AU - van Dam, G. M. AU - de Bruyn, M. AU - van Riezen, M. AU - Dijkstra, M. AU - Kamps, G. AU - Helfrich, W. AU - Haisma, H. PY - 2008 DA - 2008// TI - Potent systemic anticancer activity of adenovirally expressed EGFR-selective TRAIL fusion protein JO - Mol Ther VL - 16 UR - https://doi.org/10.1038/mt.2008.203 DO - 10.1038/mt.2008.203 ID - Bremer2008 ER - TY - JOUR AU - Stieglmaier, J. AU - Bremer, E. AU - Kellner, C. AU - Liebig, T. M. AU - Ten Cate, B. AU - Peipp, M. AU - Schulze-Koops, H. AU - Pfeiffer, M. AU - Buhring, H. J. AU - Greil, J. PY - 2008 DA - 2008// TI - Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein 274 JO - Cancer Immunol Immunother VL - 57 UR - https://doi.org/10.1007/s00262-007-0370-8 DO - 10.1007/s00262-007-0370-8 ID - Stieglmaier2008 ER - TY - JOUR AU - Muhlenbeck, F. AU - Schneider, P. AU - Bodmer, J. L. AU - Schwenzer, R. AU - Hauser, A. AU - Schubert, G. AU - Scheurich, P. AU - Moosmayer, D. AU - Tschopp, J. AU - Wajant, H. PY - 2000 DA - 2000// TI - The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.M000482200 DO - 10.1074/jbc.M000482200 ID - Muhlenbeck2000 ER - TY - JOUR AU - Ivanov, V. N. AU - Bhoumik, A. AU - Ronai, Z. PY - 2003 DA - 2003// TI - Death receptors and melanoma resistance to apoptosis JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206456 DO - 10.1038/sj.onc.1206456 ID - Ivanov2003 ER - TY - JOUR AU - Brent, P. J. AU - Pang, G. T. PY - 1995 DA - 1995// TI - [sigma] Binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture JO - European Journal of Pharmacology VL - 278 UR - https://doi.org/10.1016/0014-2999(95)00115-2 DO - 10.1016/0014-2999(95)00115-2 ID - Brent1995 ER - TY - JOUR AU - Spruce, B. A. AU - Campbell, L. A. AU - McTavish, N. AU - Cooper, M. A. AU - Appleyard, M. V. AU - O'Neill, M. AU - Howie, J. AU - Samson, J. AU - Watt, S. AU - Murray, K. PY - 2004 DA - 2004// TI - Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-3180 DO - 10.1158/0008-5472.CAN-03-3180 ID - Spruce2004 ER - TY - JOUR AU - Rybczynska, A. A. AU - Dierckx, R. A. AU - Ishiwata, K. AU - Elsinga, P. H. AU - van Waarde, A. PY - 2008 DA - 2008// TI - Cytotoxicity of sigma-receptor ligands is associated with major changes of cellular metabolism and complete occupancy of the sigma-2 subpopulation JO - J Nucl Med VL - 49 UR - https://doi.org/10.2967/jnumed.108.053876 DO - 10.2967/jnumed.108.053876 ID - Rybczynska2008 ER - TY - JOUR AU - Vilner, B. J. AU - John, C. S. AU - Bowen, W. D. PY - 1995 DA - 1995// TI - Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines JO - Cancer Res VL - 55 ID - Vilner1995 ER - TY - JOUR AU - Kurbanov, B. M. AU - Geilen, C. C. AU - Fecker, L. F. AU - Orfanos, C. E. AU - Eberle, J. PY - 2005 DA - 2005// TI - Efficient TRAIL-R1/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) 2 JO - J Invest Dermatol VL - 125 UR - https://doi.org/10.1111/j.0022-202X.2005.23900.x DO - 10.1111/j.0022-202X.2005.23900.x ID - Kurbanov2005 ER - TY - JOUR AU - Chien, A. J. AU - Moon, R. T. PY - 2007 DA - 2007// TI - WNTS and WNT receptors as therapeutic tools and targets in human disease processes JO - Front Biosci VL - 12 UR - https://doi.org/10.2741/2074 DO - 10.2741/2074 ID - Chien2007 ER - TY - JOUR AU - O'Connell, M. P. AU - Weeraratna, A. T. PY - 2009 DA - 2009// TI - Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt JO - Pigment Cell Melanoma Res VL - 22 UR - https://doi.org/10.1111/j.1755-148X.2009.00627.x DO - 10.1111/j.1755-148X.2009.00627.x ID - O'Connell2009 ER - TY - JOUR AU - Chien, A. J. AU - Moore, E. C. AU - Lonsdorf, A. S. AU - Kulikauskas, R. M. AU - Rothberg, B. G. AU - Berger, A. J. AU - Major, M. B. AU - Hwang, S. T. AU - Rimm, D. L. AU - Moon, R. T. PY - 2009 DA - 2009// TI - Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model JO - Proc Natl Acad Sci USA VL - 106 UR - https://doi.org/10.1073/pnas.0811902106 DO - 10.1073/pnas.0811902106 ID - Chien2009 ER - TY - JOUR AU - Chawla-Sarkar, M. AU - Bauer, J. AU - Lupica, J. AU - Morrison, B. AU - Tang, Z. AU - Oates, R. AU - Almasan, A. AU - DiDonato, J. AU - Borden, E. AU - Lindner, D. PY - 2003 DA - 2003// TI - Suppression of NF-+¦B Survival Signaling by Nitrosylcobalamin Sensitizes Neoplasms to the Anti-tumor Effects of Apo2L/TRAIL JO - Journal of Biological Chemistry VL - 278 UR - https://doi.org/10.1074/jbc.M306111200 DO - 10.1074/jbc.M306111200 ID - Chawla-Sarkar2003 ER - TY - JOUR AU - Gores, G. J. AU - Kaufmann, S. H. PY - 2001 DA - 2001// TI - Is TRAIL hepatotoxic? JO - Hepatology VL - 34 UR - https://doi.org/10.1053/jhep.2001.25173a DO - 10.1053/jhep.2001.25173a ID - Gores2001 ER - TY - JOUR AU - Ivanov, V. AU - Zhou, H. AU - Partridge, M. AU - Hei, T. PY - 2009 DA - 2009// TI - Inhibition of Ataxia Telangiectasia Mutated Kinase Activity Enhances TRAIL-Mediated Apoptosis in Human Melanoma Cells JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-3883 DO - 10.1158/0008-5472.CAN-08-3883 ID - Ivanov2009 ER - TY - JOUR AU - Yoshida, T. AU - Zhang, Y. AU - Rivera Rosado, L. AU - Zhang, B. PY - 2009 DA - 2009// TI - Repeated Treatment with Subtoxic Doses of TRAIL Induces Resistance to Apoptosis through Its Death Receptors in MDA-MB-231 Breast Cancer Cells JO - Molecular Cancer Research VL - 7 UR - https://doi.org/10.1158/1541-7786.MCR-09-0244 DO - 10.1158/1541-7786.MCR-09-0244 ID - Yoshida2009 ER -